BSC
JSPR icon

BOLTON SECURITIES CORPORATION’s Jasper Therapeutics JSPR Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$5.57K Buy
+78
New +$7.1K ﹤0.01% 1685
2025
Q1 		$10.1K Buy
+78
New +$15.6K ﹤0.01% 1434

Other funds holding JSPR

Velan Capital Investment Management
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Rock Springs Capital Management
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's JSPR Position: Q3 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in Jasper Therapeutics (JSPR) in Q3 2025: 78 shares worth $5.57K. The stake represents ﹤0.01% of the portfolio and ranks #1685 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in JSPR as recently as Q1 2025.

BOLTON SECURITIES CORPORATION first reported a position in JSPR in Q1 2025 and has held it in 2 quarters since. The position peaked at $10.1K in Q1 2025. 57 funds tracked by Wall St. Rank hold JSPR as of Q3 2025.

  • BOLTON SECURITIES CORPORATION held 78 shares of Jasper Therapeutics worth $5.57K as of Q3 2025.
  • Jasper Therapeutics was a new BOLTON SECURITIES CORPORATION position in Q3 2025.
  • Jasper Therapeutics made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2025, its #1685 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Jasper Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • BOLTON SECURITIES CORPORATION's Jasper Therapeutics position peaked at $10.1K in Q1 2025.
  • 57 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2025, filed 12 Nov 2026.